Related references
Note: Only part of the references are listed.Diagnosis and Outpatient Management of Chronic Obstructive Pulmonary Disease A Review
Craig M. Riley et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
Sergey Avdeev et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2019)
Clinical Pharmacology of Corticosteroids
Dennis M. Williams
RESPIRATORY CARE (2018)
Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice
Didier Cataldo et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)
Inhaled corticosteroids in COPD: friend or foe?
Alvar Agusti et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
Donald P. Tashkin et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)
Inhaled corticosteroids might not increase the risk of pneumonia in patients with chronic obstructive pulmonary disease in Japan
Ryosuke Hirano et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)
Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial
Donald P. Tashkin et al.
RESPIRATORY RESEARCH (2018)
Dual bronchodilator therapy for chronic obstructive pulmonary disease: evidence for the efficacy and Safety of fixed dose combination treatments in the setting of recent guideline updates
Steven D. Deas et al.
CURRENT OPINION IN PULMONARY MEDICINE (2018)
Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013
Kyoung Hee Cho et al.
RESPIRATORY MEDICINE (2017)
Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients
Jeong Uk Lim et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD
Christer Janson et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients' life quality with COPD in Taiwan (IMPACT) study
Cheng-Yi Wang et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2016)
Real-world research and its importance in respiratory medicine
David Price et al.
BREATHE (2015)
Pneumonia Risk with Inhaled Fluticasone Furoate and Vilanterol Compared with Vilanterol Alone in Patients with COPD
Courtney Crim et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2015)
Safety Considerations of Inhaled Corticosteroids in the Elderly
Salvatore Battaglia et al.
DRUGS & AGING (2014)
Inhaled corticosteroids and pneumonia in chronic obstructive pulmonary disease
Lydia Finney et al.
LANCET RESPIRATORY MEDICINE (2014)
Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
Kayleigh M. Kew et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Inhaled corticosteroids in COPD and the risk of serious pneumonia
Samy Suissa et al.
THORAX (2013)
Use of inhaled corticosteroids and the risk of tuberculosis
Chang-Hoon Lee et al.
THORAX (2013)
Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β2 agonist: observational matched cohort study (PATHOS)
Christer Janson et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis
Barbara P. Yawn et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2013)
Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
Luis Javier Nannini et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD
Julia Thornton Snider et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease
Luis Javier Nannini et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Reported Pneumonia in Patients With COPD Findings From the INSPIRE Study
Peter M. A. Calverley et al.
CHEST (2011)
Budesonide/formoterol vs. salmeterol/fluticasone in COPD: a systematic review and adjusted indirect comparison of pneumonia in randomised controlled trials
D. M. G. Halpin et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease
Sally Spencer et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
Performance of American Thoracic Society-Recommended Spirometry Reference Values in a Multiethnic Sample of Adults The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study
John L. Hankinson et al.
CHEST (2010)
Risk of pneumonia associated with long-term use of inhaled corticosteroids in chronic obstructive pulmonary disease: a critical review and update
Sonal Singh et al.
CURRENT OPINION IN PULMONARY MEDICINE (2010)
Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD
Min J. Joo et al.
RESPIRATORY MEDICINE (2010)
Efficacy and Tolerability of Budesonide/Formoterol Added to Tiotropium in Patients with Chronic Obstructive Pulmonary Disease
Tobias Welte et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Efficacy and Tolerability of Budesonide/Formoterol in One Hydrofluoroalkane Pressurized Metered-Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease Results from a 1-Year Randomized Controlled Clinical Trial
Stephen I. Rennard et al.
DRUGS (2009)
Efficacy and Safety of Budesonide and Formoterol in One Pressurized Metered-Dose Inhaler in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease Results of a 6-Month Randomized Clinical Trial
Donald P. Tashkin et al.
DRUGS (2008)
Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia
Pierre Ernst et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
Peter M. A. Calverley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Share Paper
